ANKRD22 and nasopharyngeal carcinoma: To probe into the biological role of ANKRD22 in NPC, we employed siRNAs targeting ANKRD22 to knock down its expression and utilized an overexpression vector (pcDNA3.1‐ANKRD22) to elevate ANKRD22 expression.